Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles

Open Access

Original Research

Impact of immunosuppressive drugs in the therapeutic efficacy of autoimmune skin diseases

Aditya Jillella, Sameer Uz Zaman, Vishnu Priya Banothu.

Background: Autoimmune skin diseases such as pemphigus vulgaris and psoriasis and systemic sclerosis require long-term treatment. Immunosuppressive drug therapy is a gold standard treatment choice in the management of autoimmune skin disease.

Aim and Objective: The aim of the study was to assess the efficacy of immunosuppressive drugs in the management of chronic skin diseases.

Materials and Methods: A total of 120 cases of both genders (75 males and 45 females), above 18 years and newly started with immunosuppressant drugs for psoriasis (methotrexate therapy-weekly once), Pemphigus Vulgaris and Systemic Sclerosis (pulse therapy monthly once) were recruited. The clinical response of drugs was assessed by psoriasis area severity index score (PASI), modified Rodnan Skin Score (MRSS), and Pemphigus Area and Activity Score (PAAS).

Results: The PAAS score, PASI score, and MRSS scores were significantly decreased from the beginning to the end of the 6th month and the difference was statistically significant (P < 0.005). Nausea/ vomiting were the common adverse effects in all groups followed by gastritis and weight gain.

Conclusion: The usage of immunosuppressant drugs such as methotrexate in the management of psoriasis and dexamethasone-cyclophosphamide therapy in the management of pemphigus vulgaris and systemic sclerosis is effective and did not show any major adverse effects.

Key words: Methotrexate Drug Therapy; Dexamethasone-cyclophosphamide Pulse Therapy; Autoimmune Skin Diseases

Similar Articles

Biovalue in Human Brain Banking: Applications and Challenges for Research in Neurodegenerative Diseases.
Vedam-Mai V
Methods in molecular biology (Clifton, N.J.). 2022; 2389(): 209-220

Effects of selenium-containing compounds on Cu/Zn-induced neuronal cell death and potential application as therapeutic agents for neurological diseases.
Tanaka KI, Shimoda M, Kawahara M
Neural regeneration research. 2022; 17(2): 311-312

Culturing and Expansion of "Clinical Grade" Neural Stem Cells from the Fetal Human Central Nervous System.
Gelati M, Profico DC, Ferrari D, Vescovi AL
Methods in molecular biology (Clifton, N.J.). 2022; 2389(): 57-66

Inserting new synaptic connections into damaged neural circuits: towards synapse therapy?
Rabinowitch I
Neural regeneration research. 2022; 17(2): 300-301

Striatal oxidative damages and neuroinflammation correlate with progression and survival of Lewy body and Alzheimer diseases.
Li H, Knight WC, Xu J
Neural regeneration research. 2022; 17(4): 867-874

Full-text options

Latest Statistics about COVID-19
• pubstat.org

Add your Article(s) to Indexes
• citeindex.org

Covid-19 Trends and Statistics
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.

ScopeMed Web Sites